Global Direct to Consumer Testing Market valued at USD 1.2 Billion in 2019 which is expected to grow at around 13% CAGR during 2020 to 2027.
Direct to consumer testing is manufactured by companies and directly provided to consumer without involvement of healthcare third party provider. Direct to consumer testing kits are affordable than genetic testing kits obtained through a healthcare provider. Direct to consumer testing market is expected to show significant growth during this forecast period due to rise in burden of various diseases like cancer and cardiovascular system diseases. In addition to that, increase in demand for ancestry DNA testing is expected to show growth of global direct to consumer testing market during this forecast period. Furthermore, increase in innovative launch in product development and rise in portfolio by various key competitors will have positive impact on global direct to consumer testing market.
Increase in awareness about genetic testing among consumer is the key driving factor which is expected to boost the global direct to consumer market growth. Furthermore, rise in prevalence of genetic diseases such as cancer, cystic fibrosis is expected to propel the global direct to consumer testing market growth.
Get Sample Copy of this Report @ https://qualiketresearch.com/request-sample/Direct-to-Consumer-Testing-Market/request-sample
North America is expected to have significant growth in global direct to consumer testing market due to increase in prevalence of genetic diseases treatments and preventions. Europe has the second largest market share due to approval activities of test kits is expected to boost the global direct to consumer testing market. Also, Asia pacific will have the significant growth in global direct to consumer testing market over the forecast period.
Market Restraints
However, lack of awareness regarding genetic testing in undeveloped countries is major restraining factor which is expected to hamper the global direct to consumer testing market. Furthermore, Also, insecurities about genetic privacy will affect the global direct to consumer testing market growth.
Market Segmentation
Global Direct to Consumer Testing Market is segmented into test type such as Carrier Screening Tests, Genetic Health Risk (GHR) Tests, Pharmacogenetics Tests, Cancer Predisposition Tests, Low Risk General Wellness Tests, Ancestry Tests, Paternity Testing, and Cancer Susceptibility Tests, by technology type such as SNP-Chip Genotyping, Whole Genome Sequencing, Next-Generation Sequencing and Sanger Sequencing. Further, Global Direct to Consumer Testing Market is segmented into sample type such as Saliva Sample, and Blood Sample, by application such as Cancer Diagnosis, Cardiovascular Disease Diagnosis, and Genetic Disease Diagnosis.
Also, Global Direct to Consumer Testing Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as Shuwen Health Sciences, Canadian DNA Services, DNA Services of America, DNA Diagnostics Center, Sure Genomics, Walk-in-Lab, Alpha Biolaboratories, MapMyGenome, Positive Bioscience, Kailos Genetics, Gene by Gene, Genomics Express, DirectLabs, DNA4Life, and 23andMe.
Market Taxonomy
By Test Type
By Technology Type
By Sample Type
By Application
By Region
Browse Full Research Report @ https://qualiketresearch.com/reports-details/Direct-to-Consumer-Testing-Market
About Us
QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.